A couple of months ago Singapore-based femtech company Ease Healthcare announced the closing of a $1.3M round to invest in expansion. Back then co-founder Guadalupe Lazaro shared: “The long-term goal is not just to tackle access to sexual and reproductive healthcare, but address the larger picture of women’s health through a truly comprehensive ecosystem of products and services.” And this week the…
Last June fertility company Kindbody known for its innovative fertility care delivery model, raised a $62M in Series C growth capital. And the company is putting the fresh funds to work. After expansion to new geographies in the U.S. throughout the second half of last year, the company is now getting serious about at-home testing and virtual care with the launch of…
Women struggling with hair loss can now get Topical Finasteride & Minoxidil Spray and Oral Spironolactone via Hers‘ telemedicine platform. The company also offers a range of other hair health related products including stand-alone Minoxidil 5% foam and Minoxidil 2% topical solution hair regrowth treatments, biotin gummies to support healthy hair, thickening shampoo and conditioner, as well as repairing hair masks and…
German telemedicine platform Wellster has added $20M in funding from Claret Capital and Mangrove Capital Partners six months after raising its initial $40M Series B. According to today’s press release the new funds will be used to “launch a new femtech vertically across Europe”, which means competition in the European women’s healthtech market is heating up. We’ve written extensively about consolidation and…
Yuvo Health wants to make value-based care delivery easier for Federally Qualified Health Centers (FQHCs) in the U.S. aka Community Health Centers by reducing the administrative burden associated with value-based care contracts. Today the company has announced the closing of a $7.3M seed round led by Alley Corp with participation from institutional investors including AV8 Ventures, New York Ventures, and Brooklyn Bridge…
Heather Delaney, the Founder and Managing Director of Gallium Ventures, a tech communications consultancy, has been the CES hero we all didn’t know we needed, but got this year. While many of us were back in yet another pandemic lockdown she was out and about and one of the around 40,000 attendees who “defied the odds” and made the trip to Las…
Celmatix, a New York-based pre-clinical stage biotech company focused on ovarian biology, has announced today that a novel PCOS target identified as part of its five-year, multi-target alliance with Evotec, has progressed into hit-identification. It may still be early in the process, but what this milestone essentially means is that Celmatix, Evotec and pharma leader Bayer, who formed a “PCOS alliance” around…
We’ve said it before and we’ll keep saying it: Pelvic Health is having a year in 2022! And today we can add another successful raise in the space to our list: Canada-based Hyivy Health has announced the closing of a $1.1M pre-seed round to continue work on its first-in-class, holistic pelvic health rehabilitation system, that combines a device as well as digital…
